Own Medibank shares? They just hit a new record high

Medibank shares are exploring uncharted territory today…

| More on:
Stethoscope with a piggy bank and hundred dollar notes.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This Tuesday is turning into a cracking one for ASX shares and the wider share market. At present, the S&P/ASX 200 Index (ASX: XJO) has vaulted a pleasing 1.12% higher and is back over 7,500 points. But let's talk about Medibank Private Ltd (ASX: MPL) shares.

As you would expect on such a strong day for ASX shares, many are doing well. But Medibank shareholders will be feeling especially chuffed. That's because shares of this ASX 200 healthcare stock have not just hit a new 52-week high, but an all-time record high.

Yep, Medibank closed at $3.70 a share yesterday. But this morning, the company surged up to a new high watermark of $3.75 a share. That's the highest level Medibank shares have ever traded at.

The company will be celebrating its tenth anniversary as an ASX share later this year (it was privatised back in 2014), so the timing is fitting.

So why is Medibank making its investors so happy this Tuesday with this new high?

Medibank shares hit new record high

Well, unfortunately for those investors who like to see cause and effect, there doesn't seem to be an obvious catalyst here. Medibank hasn't put out any fresh news or announcements in quite a while. Since 20 December in fact.

It's possible that investors are flocking to the company as a hedge against high interest rates. As my Fool colleague Tristan pointed out last month, as an insurer, Medibank benefits directly from higher rates, as the company is able to generate higher returns from its cash assets that it has to hold to pay out claims.

As we discussed then, Medibank benefitted to the tune of $78.6 million over FY23 from higher rates, with an additional $20 million benefit expected for FY24 if rates remain at their current levels.

So perhaps this is bolstering sentiment for Medibank shares. Particularly at a time when the disastrous 2022 cyber attack is probably fading in investors' minds.

Whatever the cause for Medibank's new high today, no doubt investors will be chuffed.

Medibank shares are now up over 27.8% over the past 12 months. At the current share price of $3.72, this ASX 200 healthcare stock has a market capitalisation of $10.26 billion, with a trailing dividend yield of 3.92%.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Which ASX 200 healthcare share will pay the best dividend yield in 2025?

Earnings season is underway and dividend announcements are on investors' minds.

Read more »

A person is weighed down by a huge stack of coins, they have received a big dividend payout.
Dividend Investing

Looking to bag the record high ResMed dividend? You better hurry!

Unlike the majority of ASX 200 income stocks, ResMed pays dividends every quarter.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

3 reasons to buy CSL shares today

Two investment experts expect a big turnaround for CSL shares in 2025.

Read more »

Business people discussing project on digital tablet.
Healthcare Shares

Down 4%, is the ResMed share price in the buy zone?

Do analysts think investors should be buying the dip? Let's see what they are saying.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Healthcare Shares

Guess which ASX 100 share is sinking 8% because of Trump's tariffs

Donald Trump has dealt this company a big blow. What's happening?

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Up 1,090% in a year, why is the Mesoblast share price leaping higher again on Friday?

Mesoblast shares have surged more than 1,000% over the last 12 months.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Earnings Results

ResMed shares rise on strong Q2 result

Let's see how this sleep treatment company performed during the second quarter.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

$1,000 invested in Mesoblast shares at the start of 2024 is now worth…

Did this biotech company deliver the goods for investors? Let's see what a $1,000 investment would be worth.

Read more »